SecSonar.com

Warby Parker Inc. (WRBY)

Warby Parker Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Warby Parker Inc. (WRBY) is a Medical - Instruments & Supplies company based in US with a market capitalization of $3B. Revenue grew 13.0% year-over-year and the company generated $43.7M in free cash flow. This page tracks WRBY's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 2.22K employees · IPO Sep 29, 2021

Valuation

Valuation & price

$28.73 · as of May 17, 2026 · -5.3% vs 52w high

2190.2

P/E ratio

Latest-FY diluted EPS

8.25

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$29.57$23.25$16.93Jul 25Dec 25Jul 26Jul 7, 25$21.37Jul 9, 25$22.27Jul 11, 25$22.20Jul 15, 25$22.90Jul 17, 25$23.45Jul 21, 25$24.29Jul 23, 25$24.46Jul 25, 25$24.39Jul 29, 25$23.75Jul 31, 25$23.95Aug 4, 25$24.49Aug 6, 25$24.30Aug 11, 25$23.22Aug 13, 25$26.81Aug 15, 25$27.13Aug 19, 25$26.37Aug 21, 25$26.07Aug 25, 25$26.16Aug 27, 25$26.53Aug 29, 25$26.20Sep 3, 25$25.26Sep 5, 25$26.02Sep 9, 25$26.96Sep 11, 25$27.55Sep 16, 25$27.14Sep 18, 25$28.34Sep 22, 25$28.56Sep 24, 25$28.20Sep 26, 25$27.60Sep 30, 25$27.58Oct 2, 25$26.44Oct 6, 25$25.36Oct 8, 25$24.60Oct 10, 25$22.26Oct 14, 25$22.14Oct 16, 25$21.53Oct 21, 25$21.73Oct 23, 25$22.16Oct 27, 25$21.50Oct 29, 25$20.05Oct 31, 25$19.59Nov 4, 25$19.65Nov 6, 25$16.93Nov 10, 25$17.39Nov 12, 25$17.49Nov 14, 25$16.96Nov 18, 25$17.15Nov 20, 25$17.01Nov 25, 25$19.99Nov 28, 25$19.81Dec 2, 25$18.50Dec 4, 25$18.42Dec 8, 25$21.26Dec 10, 25$29.57Dec 12, 25$27.40Dec 16, 25$26.65Dec 18, 25$26.73Dec 22, 25$26.52Dec 24, 25$26.33Dec 29, 25$23.00Jan 2, 26$22.62Jan 6, 26$25.94Jan 8, 26$28.28Jan 12, 26$26.58Jan 14, 26$28.79Jan 16, 26$28.16Jan 21, 26$26.43Jan 23, 26$26.38Jan 27, 26$27.29Jan 29, 26$26.86Feb 2, 26$26.03Feb 4, 26$26.37Feb 9, 26$24.14Feb 11, 26$21.99Feb 13, 26$22.46Feb 18, 26$22.74Feb 20, 26$23.71Feb 24, 26$22.24Feb 26, 26$25.65Mar 2, 26$26.29Mar 4, 26$27.36Mar 6, 26$24.82Mar 10, 26$25.54Mar 12, 26$23.51Mar 17, 26$23.59Mar 19, 26$24.37Mar 23, 26$24.18Mar 25, 26$23.38Mar 27, 26$20.33Mar 31, 26$21.07Apr 2, 26$20.29Apr 7, 26$21.19Apr 9, 26$20.94Apr 13, 26$21.28Apr 15, 26$23.66Apr 17, 26$24.86Apr 22, 26$24.58Apr 24, 26$22.81Apr 28, 26$22.53Apr 30, 26$22.12May 4, 26$21.99May 6, 26$22.03May 8, 26$29.55May 12, 26$26.95May 14, 26$28.90May 18, 26$28.65May 20, 26$24.45May 22, 26$25.09May 28, 26$25.72Jun 1, 26$24.38Jun 3, 26$24.22Jun 5, 26$22.72Jun 9, 26$24.82Jun 11, 26$25.86Jun 15, 26$26.38Jun 17, 26$24.22Jun 22, 26$26.99Jun 24, 26$26.85Jun 26, 26$29.24Jul 2, 26$29.26
$16.4952-week range$30.34
Loading valuation history…

Fundamentals

Key fundamentals

$3B

Market cap

13.0%

Revenue growth (YoY)

54.0%

Gross margin

$43.7M

Free cash flow (USD)

-$53.2M

Net debt

Net cash position

1.9%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$370.5MFY 2020$393.7MFY 2021$540.8MFY 2022$598.1MFY 2023$669.8MFY 2024$771.3MFY 2025$871.9M
$370.5M$871.9M

Free cash flow by year

2019 → 2025

FY 2019$-11.2MFY 2020$12.7MFY 2021$-80.5MFY 2022$-49.8MFY 2023$7.3MFY 2024$34.7MFY 2025$43.7M
-$11.2M$43.7M

Gross margin by year

2021 → 2025

FY 202158.8%FY 202257.0%FY 202354.5%FY 202455.3%FY 202554.0%
58.8%54.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

9

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $669K · 10b5-1 PlanRaider Jeffrey Jacob · Director · $668.7KJul 2, 2026Filing
  • Insider sellInsider Sell $7.2M · 10b5-1 PlanGilboa David Abraham · Director, Co-Chief Executive Officer · $7.2MJul 2, 2026Filing
  • Insider sellInsider Sell $6.4M · 10b5-1 PlanBlumenthal Neil Harris · Director, Co-Chief Executive Officer · $6.4MJul 2, 2026Filing
  • Insider sellInsider Sell $1.1M · 10b5-1 PlanBlumenthal Neil Harris · Director, Co-Chief Executive Officer · $1.1MJul 1, 2026Filing
  • Insider sellInsider Sell $130K · 10b5-1 PlanBriggs Teresa · Director · $129.7KJun 18, 2026Filing
  • Insider sellInsider Sell $265KMoon Youngme E · Director · $265.3KJun 12, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 12, 2026Filing
  • Insider sellInsider Sell $1.9M · 10b5-1 PlanBlumenthal Neil Harris · Director, Co-Chief Executive Officer · $1.9MMay 21, 2026Filing
  • Insider sellInsider Sell $715KSINGER BRADLEY E · Director · $715.2KMay 15, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing

Questions

Frequently asked questions

What is Warby Parker Inc.'s market cap?

Warby Parker Inc. (WRBY) has a market capitalization of $3B.

What is WRBY's P/E ratio?

WRBY trades at a price-to-earnings ratio of 2190.2, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is WRBY's price-to-book (P/B) ratio?

WRBY trades at 8.25 times book value per share.

Are insiders buying WRBY stock?

SEC Form 4 filings show no open-market insider buys at Warby Parker Inc. in the last 90 days (9 sells).

Same arena

Related companies in Medical - Instruments & Supplies

HAE

Haemonetics Corporation

$3.1B

ICUI

ICU Medical, Inc.

$3.4B

MMSI

Merit Medical Systems, Inc.

$3.8B

LMAT

LeMaitre Vascular, Inc.

$2.2B

XRAY

DENTSPLY SIRONA Inc.

$2.1B

NVCR

NovoCure Limited

$2B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.